Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)

Y. Tao , A. Auperin , X. Sun , C. Sire , L. Martin , Alexandre Coutte (1) , C. Lafond , J. Miroir , X. Liem , F. Rolland , A. Maillard , N. Colin-Barailhou , C. Michel , J. Thariat , J. Guigay , J. Bourhis

1 CHIMERE - CHirurgie, IMagerie et REgénération tissulaire de l’extrémité céphalique - Caractérisation morphologique et fonctionnelle - UR UPJV 7516

Domaines: Sciences du Vivant [q-bio]

Y. Tao, A. Auperin, X. Sun, C. Sire, L. Martin, et al.. Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH). Annals of Oncology, 2019, 30 (5), pp.454. ⟨hal-03600474⟩